Athira Pharma Inc. (ATHA)
NASDAQ: ATHA
· Real-Time Price · USD
0.33
-0.03 (-8.33%)
At close: Jun 09, 2025, 3:59 PM
Athira Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | 1.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | 242K | 242K | 245K | 244K | 297K | 287K | 288K | 293K | 268K | 199K | 126K | 123K | 118K | 112K |
Gross Profit | n/a | n/a | n/a | -242K | -242K | 1.41M | -244K | -297K | -287K | -288K | -293K | -268K | -199K | -126K | -123K | -118K | -112K |
Operating Income | -9.54M | -15.57M | -29.62M | -28.03M | -27.69M | -30.64M | -35.04M | -31.64M | -29.77M | -32.93M | -24.13M | -23.57M | -23.39M | -18.78M | -17.83M | -16.64M | -10.78M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 1.73M | 2.07M | 2.04M | 1.79M | n/a | 987K | 493K | 175K | 105K | 74K | 74K | 84K |
Pretax Income | -9.14M | -15M | -28.74M | -26.86M | -26.34M | -27.29M | -32.97M | -29.6M | -27.82M | -30.14M | -20.19M | -24.34M | -20.98M | -16.34M | -15.67M | -13.97M | -8.87M |
Net Income | -9.14M | -15M | -28.74M | -26.86M | -26.34M | -27.29M | -32.97M | -29.6M | -25.87M | -25.7M | -16.25M | -24.34M | -18.57M | -16.34M | -15.67M | -13.97M | -8.87M |
Selling & General & Admin | 5.23M | 6.2M | 7.57M | 5.87M | 6.45M | 6.96M | 7.84M | 10.03M | 8.48M | 7.69M | 7.17M | 8.77M | 8.93M | 6.16M | 7.12M | 4.61M | 3.34M |
Research & Development | 4.3M | 9.37M | 17.92M | 21.91M | 20.99M | 23.43M | 27.2M | 21.61M | 21.29M | 15.24M | 16.96M | 14.8M | 14.46M | 12.62M | 10.71M | 12.02M | 7.45M |
Other Expenses | n/a | n/a | 4.13M | 1.17M | 1.35M | 1.73M | 2.07M | 2.04M | -157K | -1.23M | -2.96M | 493K | -2.23M | 6.5M | -2.08M | -2.59M | -1.83M |
Operating Expenses | 9.54M | 15.57M | 29.62M | 27.79M | 27.45M | 30.4M | 35.04M | 31.64M | 29.61M | 21.7M | 21.17M | 24.83M | 21.15M | 16.44M | 15.75M | 14.05M | 8.95M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 1.95M | n/a | n/a | n/a | n/a | 987K | n/a | 2K | 2K | 1K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 15.57M | 29.62M | 28.03M | 27.69M | 30.64M | 35.04M | 31.64M | 29.61M | 21.7M | 21.17M | 24.83M | 21.15M | 16.44M | 15.75M | 14.05M | 8.95M |
Income Tax Expense | n/a | n/a | n/a | n/a | 198.72K | 2.19M | -244K | 121.92K | -1.95M | -4.43M | -3.94M | -47K | -2.41M | 1.98M | 2.15M | 2.59M | 1.92M |
Shares Outstanding (Basic) | 39.04M | 38.48M | 38.52M | 38.38M | 38.32M | 38.11M | 38.05M | 38M | 37.92M | 37.82M | 37.82M | 37.67M | 37.59M | 37.38M | 37.31M | 37.21M | 35.78M |
Shares Outstanding (Diluted) | 39.04M | 38.48M | 38.52M | 38.38M | 38.32M | 38.11M | 38.05M | 38M | 37.92M | 37.82M | 37.82M | 37.67M | 37.59M | 37.38M | 37.31M | 37.21M | 35.78M |
EPS (Basic) | -0.23 | -0.39 | -0.75 | -0.7 | -0.69 | -0.72 | -0.87 | -0.78 | -0.68 | -0.68 | -0.43 | -0.65 | -0.49 | -0.44 | -0.42 | -0.38 | -0.25 |
EPS (Diluted) | -0.23 | -0.39 | -0.75 | -0.7 | -0.69 | -0.72 | -0.87 | -0.78 | -0.68 | -0.68 | -0.43 | -0.65 | -0.49 | -0.44 | -0.42 | -0.38 | -0.25 |
EBITDA | -9.54M | -15.32M | -25.25M | -27.79M | -27.45M | -30.4M | -34.8M | -31.4M | -29.53M | -22.69M | -19.9M | -24.07M | -20.78M | -16.21M | -15.55M | -13.86M | -8.75M |
EBIT | n/a | -15.57M | -25.49M | -28.03M | -27.69M | -30.64M | -35.04M | -31.64M | -29.77M | -21.7M | -20.19M | -24.34M | -20.98M | -16.34M | -15.67M | -13.97M | -8.87M |
Depreciation & Amortization | n/a | 243K | 243K | 242K | 242K | 245K | 244K | 297K | 287K | 288K | 293K | 268K | 199K | 126K | 123K | 118K | 112K |